ORG Partners LLC Acquires Shares of 1,678 Axon Enterprise, Inc (NASDAQ:AXON)

ORG Partners LLC bought a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON) in the first quarter, HoldingsChannel reports. The institutional investor bought 1,678 shares of the biotechnology company’s stock, valued at approximately $908,000.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. CX Institutional acquired a new stake in Axon Enterprise during the first quarter worth approximately $115,000. Principal Securities Inc. increased its stake in shares of Axon Enterprise by 255.7% during the fourth quarter. Principal Securities Inc. now owns 1,085 shares of the biotechnology company’s stock worth $645,000 after purchasing an additional 780 shares during the period. Xponance Inc. lifted its holdings in Axon Enterprise by 3.5% during the 4th quarter. Xponance Inc. now owns 16,469 shares of the biotechnology company’s stock worth $9,788,000 after purchasing an additional 560 shares during the last quarter. Brighton Jones LLC acquired a new stake in Axon Enterprise during the 4th quarter worth approximately $480,000. Finally, Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in Axon Enterprise by 16.2% in the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 12,200 shares of the biotechnology company’s stock valued at $7,251,000 after purchasing an additional 1,700 shares during the period. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares of the company’s stock, valued at approximately $1,657,583,622.18. The trade was a 0.33% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Joshua Isner sold 9,905 shares of the firm’s stock in a transaction dated Wednesday, May 21st. The shares were sold at an average price of $738.03, for a total value of $7,310,187.15. Following the completion of the sale, the president now directly owns 298,809 shares in the company, valued at $220,530,006.27. This trade represents a 3.21% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 44,642 shares of company stock valued at $30,500,428. 4.40% of the stock is currently owned by corporate insiders.

Axon Enterprise Price Performance

AXON stock opened at $770.79 on Friday. The company’s 50-day moving average price is $687.97 and its two-hundred day moving average price is $625.39. The firm has a market cap of $60.01 billion, a P/E ratio of 186.18, a P/E/G ratio of 88.73 and a beta of 1.29. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. Axon Enterprise, Inc has a 12 month low of $279.02 and a 12 month high of $806.64.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The business had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. During the same quarter last year, the business posted $1.15 EPS. The firm’s revenue for the quarter was up 31.3% on a year-over-year basis. On average, analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Analyst Ratings Changes

AXON has been the topic of several recent research reports. Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Bank of America raised their price target on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a “buy” rating in a research report on Wednesday, June 4th. Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a report on Thursday, May 8th. The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a research report on Wednesday, May 14th. Finally, Barclays lifted their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an “overweight” rating in a research report on Friday, May 9th. One analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $699.55.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.